Glenzocimab
Glenzocimab (ACT017), a Fab fragment of a humanized anti-GPVI monoclonal antibody, demonstrated inhibition of collagen-induced platelet aggregation in an ischemic stroke model and has been studied in acute ischemic stroke and cerebral thrombosis.
Product Specifications
CAS Number
2101829-58-5
Stability
≥ 2 years
Purity
>98% (HPLC)
Molecular Formula
——
Notes
Research use only, not for human use.
Receptor
Others
Available Sizes
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
LS063877 100 µg
C10orf84 (FAM204A) (NM_022063) Human Over-expression Lysate
Sign In for Pricing
View Details 
MBS1205254-01 0.02 mg (E-Coli)
Recombinant Saccharomyces cerevisiae Mating-type protein A1 (MATA1)
Sign In for Pricing
View Details MBS1205254-02 0.1 mg (E-Coli)
Recombinant Saccharomyces cerevisiae Mating-type protein A1 (MATA1)
Sign In for Pricing
View Details MBS1205254-03 0.02 mg (Yeast)
Recombinant Saccharomyces cerevisiae Mating-type protein A1 (MATA1)
Sign In for Pricing
View Details MBS1205254-04 0.1 mg (Yeast)
Recombinant Saccharomyces cerevisiae Mating-type protein A1 (MATA1)
Sign In for Pricing
View Details